Understanding the Late Effects of Surviving a Pediatric Brain Tumor



Status:Recruiting
Conditions:Cancer, Cancer, Brain Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:6 - 16
Updated:8/24/2018
Start Date:June 28, 2017
End Date:June 2019
Contact:Stephen Sands, PsyD
Email:sandss@mskcc.org
Phone:646-888-0023

Use our guide to learn which trials are right for you!

Biological Substrates of Impaired Neurocognitive Functioning: Understanding the Late Effects of Surviving a Pediatric Brain Tumor

The goal of this study is to learn about the cognitive and behavioral functioning of children
being treated for cancer.


Inclusion Criteria:

Children Treated for Posterior Fossa Tumors:

- As per medical record or clinical report, successfully completed all medical treatment
for either an M0 posterior fossa medulloblastoma without dissemination or posterior
fossa low-grade astrocytoma without relapse or evidence of residual disease.

- For medulloblastoma survivors only: Previously treated with gross total resection
(GTR), craniospinal irradiation with conformal posterior fossa boost radiotherapy (CSI
+ Boost) and chemotherapy

- For low grade astrocytoma survivors only: Previously treated with gross total
resection ONLY (no chemotherapy or radiotherapy).

- As per medical record or clinician report, between 1-10 years post completion of their
medical treatment for their posterior fossa brain tumor.

- Subject is between the ages of 6 through 16 years at time of consent.

- As per medical record or parent report, subject is able to tolerate an MRI without
sedation.

Healthy Control Participants:

- No major medical illness, as determined by medical interview by study physician.

- As per parent report, subject is between the ages of 6 through 16 years at time of
consent.

- As per parent report, subject is able to tolerate an MRI without sedation.

Exclusion Criteria:

All Participants:

- Full Scale IQ as documented to be below a standard score of <70 based upon the study
IQ assessment completed after consent.

- As per self or parent report, completed any portion of the neuropsychological battery
used in this study within the last year.

- MRI contraindications (e.g., implanted ferromagnetic devices, claustrophobia) as per
radiology clinical operating procedures.

- As per self or parent report or medical record, currently taking medications that have
CNS effects (i.e., antidepressants, neuroleptics, anti-seizure medications, drugs that
affect blood pressure or heart rate, alpha-agonists, adrenergic blockers, lithium,
sedating antihistamines, and some medications for the treatment of asthma).

- As per self or parent report, non-fluency in English language as demonstrated by
current educational placement in a non-English-speaking classroom setting.
We found this trial at
3
sites
1275 York Ave
New York, New York 10021
(212) 639-2000
Principal Investigator: Stephen Sands, PsyD
Phone: 646-888-0023
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
?
mi
from
New York, NY
Click here to add this to my saved trials
1801 Inwood Rd
Dallas, Texas 75390
(214) 645-3300
Phone: 214-730-5437
University of Texas Southwestern Medical Center UT Southwestern is an academic medical center, world-renowned for...
?
mi
from
Dallas, TX
Click here to add this to my saved trials
4800 Sand Point Way NE
Seattle, Washington 98105
(206) 987-2000
Principal Investigator: Dennis W Shaw, MD
Phone: 206-987-2134
Seattle Children's Hospital Seattle Children’s Hospital specializes in meeting the unique physical, emotional and developmental...
?
mi
from
Seattle, WA
Click here to add this to my saved trials